Both in Biotechnology
MiNK Therapeutics vs Cardiff Oncology
Over the past year INKT returned −17.5% and CRDF returned −62.9%; their daily moves had a correlation of 0.11.
INKT −17.5% CRDF −62.9%Growth of $1, one year, split-adjusted
| Metric | INKT | CRDF |
|---|---|---|
| Price | $11.10 | $0.8579 |
| Market cap | $56.6M | $66.7M |
| Today | +0.54% | +1.61% |
| 1 month | −9.0% | −24.7% |
| 6 months | −3.8% | −46.7% |
| Year to date | −0.4% | −69.5% |
| 1 year | −20.9% | −63.5% |
| Revenue growth (YoY) | — | −14.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −8882.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 131.4× |
| Net cash | $8.8M | $34.5M |
| Dividend yield | — | — |
| Volatility (60d) | 50.9% | 71.6% |
| Short % of float | 2.4% | 17.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).